Schizophrenia is a chronic and debilitating mental illness that affects about 1 percent of the population worldwide, casting a long shadow over the lives of individuals and their families. It’s a ...
Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have uncovered a strikingly similar suite of changes in gene activity in brain tissue from people ...
Scientists from the universities of Granada (Spain) and Washington in St Louis (US) have found that there is not a single type of schizophrenia, but that it consists of a group made up of eight ...
Neurodiversity could be broadly thought of as a celebration of the many ways of thinking, feeling, and interacting with the world. Neurodivergent individuals are those whose brains process information ...
UCSF researcher Daniel Mathalon, MD, PhD, believes that burgeoning knowledge about biomarkers — biological measures of a ...
Other cells, such as glial cells, support the function of neurons. Neuroscience has often painted glial cells as the glue that holds neurons together, but glial cells can also be helpful in promoting ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to ...
How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia. Current ...
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results